New cancer clinical trial: Vaccine + Durvalumab in Human Papilloma Virus (HPV) Cancers

Published on: February 20, 2018 at 12:00PM
Conditions:   Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Female Genital Organs;   Malignant Neoplasms of Male Genital Organs;   Human Papilloma Virus
Interventions:   Biological: MEDI0457;   Drug: Durvalumab;   Procedure: Electroporation
Sponsors:   M.D. Anderson Cancer Center;   AstraZeneca;   Inovio Pharmaceuticals
Not yet recruiting
http://ift.tt/2FjqQgL